F Bernard1, J Outtrim, D K Menon, B F Matta. 1. University Department of Critical Care Medicine and General Internal Medicine, Hôpital du Sacré-Coeur, Montréal, Québec, Canada. bernard.francis@gmail.com
Abstract
BACKGROUND: Adrenal insufficiency impacts on the haemodynamic management of patients in intensive care. Very little is known about the incidence of adrenal insufficiency in the first 10 days after traumatic brain injury. METHODS: We retrospectively reviewed the charts of 113 traumatic brain injury patients within 10 days of their injury. They all had a high-dose corticotropin stimulation test performed because of haemodynamic instability. Blood cortisol concentrations were measured at baseline, 30 and 60 min after the administration of high-dose corticotropin. The incidence of adrenal insufficiency was determined according to various definitions used in the literature. RESULTS: The baseline cortisol concentration was <414 nmol litre(-1) (15 microg dl(-1)) in 78% of patients and <690 nmol litre(-1) (25 microg dl(-1)) in all patients. The cortisol concentration did not rise above 500 nmol litre(-1) (18 microg dl(-1)) at 30 and 60 min in 49 and 22% of patients, respectively. The cortisol concentration did not rise by 250 nmol litre(-1) (9 microg dl(-1)) at 30 and 60 min in 48 and 25% of patients respectively. Primary adrenal insufficiency defined by an abnormal baseline cortisol concentration and an abnormal response to the high-dose corticotropin stimulation test was present in 13-28% of patients according to the cut-off values used. CONCLUSIONS: The incidence of adrenal insufficiency varies from 25 to 100% in the first 10 days after traumatic brain injury. The range of incidences reported illustrates the need for standardization of the definition of adrenal insufficiency. This has a direct impact on treatment. Sampling at 60 min after the high-dose corticotropin stimulation test seems to correlate better with the maximum secreting capacity of the adrenal glands.
BACKGROUND: Adrenal insufficiency impacts on the haemodynamic management of patients in intensive care. Very little is known about the incidence of adrenal insufficiency in the first 10 days after traumatic brain injury. METHODS: We retrospectively reviewed the charts of 113 traumatic brain injury patients within 10 days of their injury. They all had a high-dose corticotropin stimulation test performed because of haemodynamic instability. Blood cortisol concentrations were measured at baseline, 30 and 60 min after the administration of high-dose corticotropin. The incidence of adrenal insufficiency was determined according to various definitions used in the literature. RESULTS: The baseline cortisol concentration was <414 nmol litre(-1) (15 microg dl(-1)) in 78% of patients and <690 nmol litre(-1) (25 microg dl(-1)) in all patients. The cortisol concentration did not rise above 500 nmol litre(-1) (18 microg dl(-1)) at 30 and 60 min in 49 and 22% of patients, respectively. The cortisol concentration did not rise by 250 nmol litre(-1) (9 microg dl(-1)) at 30 and 60 min in 48 and 25% of patients respectively. Primary adrenal insufficiency defined by an abnormal baseline cortisol concentration and an abnormal response to the high-dose corticotropin stimulation test was present in 13-28% of patients according to the cut-off values used. CONCLUSIONS: The incidence of adrenal insufficiency varies from 25 to 100% in the first 10 days after traumatic brain injury. The range of incidences reported illustrates the need for standardization of the definition of adrenal insufficiency. This has a direct impact on treatment. Sampling at 60 min after the high-dose corticotropin stimulation test seems to correlate better with the maximum secreting capacity of the adrenal glands.
Authors: J A Llompart-Pou; G Pérez; J Pérez-Bárcena; M Brell; J Ibáñez; M Riesco; J M Abadal; J Homar; P Marsé; J Ibáñez; B Burguera; J M Raurich Journal: J Endocrinol Invest Date: 2010-06 Impact factor: 4.256
Authors: R S Wijesurendra; F Bernard; J Outtrim; B Maiya; S Joshi; P J Hutchinson; D J Halsall; D K Menon Journal: Neurocrit Care Date: 2009-04-29 Impact factor: 3.210
Authors: Juan A Llompart-Pou; Joan M Raurich; Jon Pérez-Bárcena; Antonia Barceló; Jordi Ibáñez; José I Ayestarán Journal: Neurocrit Care Date: 2008 Impact factor: 3.210
Authors: Cameron P Upchurch; Carlos G Grijalva; Stephan Russ; Sean P Collins; Matthew W Semler; Todd W Rice; Dandan Liu; Jesse M Ehrenfeld; Kevin High; Tyler W Barrett; Candace D McNaughton; Wesley H Self Journal: Ann Emerg Med Date: 2017-01 Impact factor: 5.721